These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8194887)

  • 1. Immunotherapy with antibodies to the EGF receptor.
    Dean C; Modjtahedi H; Eccles S; Box G; Styles J
    Int J Cancer Suppl; 1994; 8():103-7. PubMed ID: 8194887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction.
    Modjtahedi H; Eccles S; Box G; Styles J; Dean C
    Br J Cancer; 1993 Feb; 67(2):254-61. PubMed ID: 7679281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.
    Modjtahedi H; Styles JM; Dean CJ
    Br J Cancer; 1993 Feb; 67(2):247-53. PubMed ID: 8094290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti-EGFR MAb ICR62: a two-pronged attack for tumour therapy.
    Modjtahedi H; Moscatello DK; Box G; Green M; Shotton C; Lamb DJ; Reynolds LJ; Wong AJ; Dean C; Thomas H; Eccles S
    Int J Cancer; 2003 Jun; 105(2):273-80. PubMed ID: 12673691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer.
    Modjtahedi H; Hickish T; Nicolson M; Moore J; Styles J; Eccles S; Jackson E; Salter J; Sloane J; Spencer L; Priest K; Smith I; Dean C; Gore M
    Br J Cancer; 1996 Jan; 73(2):228-35. PubMed ID: 8546911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of combinations of antibodies directed against different epitopes on the extracellular domain of the human EGF receptor.
    Modjtahedi H; Eccles SA; Box G; Styles J; Dean CJ
    Cell Biophys; 1993; 22(1-3):129-46. PubMed ID: 7534211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.
    Modjtahedi H; Eccles S; Sandle J; Box G; Titley J; Dean C
    Cancer Res; 1994 Apr; 54(7):1695-701. PubMed ID: 8137284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
    Baselga J; Norton L; Masui H; Pandiella A; Coplan K; Miller WH; Mendelsohn J
    J Natl Cancer Inst; 1993 Aug; 85(16):1327-33. PubMed ID: 8340945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours.
    Modjtahedi H; Komurasaki T; Toyoda H; Dean C
    Int J Cancer; 1998 Jan; 75(2):310-6. PubMed ID: 9462724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The binding of HB-EGF to tumour cells is blocked by mAbs which act as EGF and TGF alpha antagonists.
    Modjtahedi H; Dean C
    Biochem Biophys Res Commun; 1995 Feb; 207(1):389-97. PubMed ID: 7857293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidermal growth factor receptor as a target for therapy in breast carcinoma.
    Baselga J; Mendelsohn J
    Breast Cancer Res Treat; 1994 Jan; 29(1):127-38. PubMed ID: 8018961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth.
    Harwerth IM; Wels W; Schlegel J; Müller M; Hynes NE
    Br J Cancer; 1993 Dec; 68(6):1140-5. PubMed ID: 7903153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor activity of monoclonal antibody CIBCNSH3 generated to the human EGF receptor.
    Udayachander M; Dean CJ; Meenakshi AN; Sivakumar N; Babu PB; Sivakumar J
    Hum Antibodies; 1997; 8(2):60-4. PubMed ID: 9289389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours.
    Nilsson O; Wängberg B; Kölby L; Schultz GS; Ahlman H
    Int J Cancer; 1995 Mar; 60(5):645-51. PubMed ID: 7860139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.
    Brown PM; Debanne MT; Grothe S; Bergsma D; Caron M; Kay C; O'Connor-McCourt MD
    Eur J Biochem; 1994 Oct; 225(1):223-33. PubMed ID: 7925442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of transforming growth factor-alpha (TGF-alpha) in basal and hormone-stimulated growth by estradiol, prolactin and progesterone in human and rat mammary tumor cells: studies using TGF-alpha and EGF receptor antibodies.
    Ahmed SR; Badger B; Wright C; Manni A
    J Steroid Biochem Mol Biol; 1991 Jun; 38(6):687-93. PubMed ID: 2064983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential role of transforming growth factor-alpha in two human colon-carcinoma cell lines.
    Watkins LF; Levine AE
    Int J Cancer; 1991 Feb; 47(3):455-60. PubMed ID: 1993555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5.
    Modjtahedi H; Affleck K; Stubberfield C; Dean C
    Int J Oncol; 1998 Aug; 13(2):335-42. PubMed ID: 9664130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines.
    Werner MH; Humphrey PA; Bigner DD; Bigner SH
    Acta Neuropathol; 1988; 77(2):196-201. PubMed ID: 3265834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.